Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey

M. Rosinska, Lorenzo Gios, Christiana Nöstlinger, Wim Vanden Berghe, Marcus Ulrich, Susanne Schink, Nigel Sherriff, Anna-Marie Jones, Cinta Folch, Sonia Dias, Inga Velicko, Massimo Mirandola

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background Substance use has been consistently reported to be more prevalent amongst Men who have Sex with Men (MSM) compared to the general population. Substance use, in particular polydrug use, has been found to be influenced by social and contextual factors and to increase the risk of unprotected intercourse among MSM. The objective of this analysis was to investigate the prevalence and predictors of drug use during a sexual encounter and to identify specific prevention needs. Methods/Design A multi-site bio-behavioural cross-sectional survey was implemented in 13 European cities, targeting MSM and using Time-Location Sampling and Respondent-Driven Sampling methods. Multivariable multi-level logistic random-intercept model (random effect of study site) was estimated to identify factors associated with the use of alcohol, cannabis, party drugs, sexual performance enhancement drugs and chemsex drugs. Results Overall, 1,261 (30.0%) participants reported drug use, and 436 of 3,706 (11.8%) reported the use of two or more drugs during their last sexual encounter. By drug class, 966 (23.0%) reported using sexual performance enhancement drugs, 353 (8.4%) - party drugs, and 142 (3.4%) the use of chemsex drugs. Respondents who reported drug use were more frequently diagnosed with HIV (10.5% vs. 3.9%) before and with other STIs during the 12 months prior to the study (16.7% vs. 9.2%). The use of all the analysed substances was significantly associated with sexual encounter with more than one partner. Discussion Substance and polydrug use during sexual encounters occurred amongst sampled MSM across Europe although varying greatly between study sites. Different local social norms within MSM communities may be important contextual drivers of drug use, highlighting the need for innovative and multi-faceted prevention measures to reduce HIV/STI risk in the context of drug use.
Original languageEnglish
Pages (from-to)231-241
Number of pages11
JournalInternational Journal of Drug Policy
Volume55
DOIs
Publication statusPublished - 7 May 2018

Fingerprint

Pharmaceutical Preparations
Sexually Transmitted Diseases
Surveys and Questionnaires
HIV
Cannabis
Cross-Sectional Studies
Alcohols
Population

Bibliographical note

© 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

Keywords

  • MSM
  • Drug use
  • Recreational drug use
  • Time-location sampling
  • Respondent-driven sampling
  • Europe

Cite this

Rosinska, M., Gios, L., Nöstlinger, C., Vanden Berghe, W., Ulrich, M., Schink, S., ... Mirandola, M. (2018). Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey. International Journal of Drug Policy, 55, 231-241. https://doi.org/10.1016/j.drugpo.2018.01.002
Rosinska, M. ; Gios, Lorenzo ; Nöstlinger, Christiana ; Vanden Berghe, Wim ; Ulrich, Marcus ; Schink, Susanne ; Sherriff, Nigel ; Jones, Anna-Marie ; Folch, Cinta ; Dias, Sonia ; Velicko, Inga ; Mirandola, Massimo. / Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey. In: International Journal of Drug Policy. 2018 ; Vol. 55. pp. 231-241.
@article{604a2a4eb0fb4ba69850cbb47f1026e2,
title = "Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey",
abstract = "Background Substance use has been consistently reported to be more prevalent amongst Men who have Sex with Men (MSM) compared to the general population. Substance use, in particular polydrug use, has been found to be influenced by social and contextual factors and to increase the risk of unprotected intercourse among MSM. The objective of this analysis was to investigate the prevalence and predictors of drug use during a sexual encounter and to identify specific prevention needs. Methods/Design A multi-site bio-behavioural cross-sectional survey was implemented in 13 European cities, targeting MSM and using Time-Location Sampling and Respondent-Driven Sampling methods. Multivariable multi-level logistic random-intercept model (random effect of study site) was estimated to identify factors associated with the use of alcohol, cannabis, party drugs, sexual performance enhancement drugs and chemsex drugs. Results Overall, 1,261 (30.0{\%}) participants reported drug use, and 436 of 3,706 (11.8{\%}) reported the use of two or more drugs during their last sexual encounter. By drug class, 966 (23.0{\%}) reported using sexual performance enhancement drugs, 353 (8.4{\%}) - party drugs, and 142 (3.4{\%}) the use of chemsex drugs. Respondents who reported drug use were more frequently diagnosed with HIV (10.5{\%} vs. 3.9{\%}) before and with other STIs during the 12 months prior to the study (16.7{\%} vs. 9.2{\%}). The use of all the analysed substances was significantly associated with sexual encounter with more than one partner. Discussion Substance and polydrug use during sexual encounters occurred amongst sampled MSM across Europe although varying greatly between study sites. Different local social norms within MSM communities may be important contextual drivers of drug use, highlighting the need for innovative and multi-faceted prevention measures to reduce HIV/STI risk in the context of drug use.",
keywords = "MSM, Drug use, Recreational drug use, Time-location sampling, Respondent-driven sampling, Europe",
author = "M. Rosinska and Lorenzo Gios and Christiana N{\"o}stlinger and {Vanden Berghe}, Wim and Marcus Ulrich and Susanne Schink and Nigel Sherriff and Anna-Marie Jones and Cinta Folch and Sonia Dias and Inga Velicko and Massimo Mirandola",
note = "{\circledC} 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/",
year = "2018",
month = "5",
day = "7",
doi = "10.1016/j.drugpo.2018.01.002",
language = "English",
volume = "55",
pages = "231--241",
journal = "International Journal of Drug Policy",
issn = "0955-3959",

}

Rosinska, M, Gios, L, Nöstlinger, C, Vanden Berghe, W, Ulrich, M, Schink, S, Sherriff, N, Jones, A-M, Folch, C, Dias, S, Velicko, I & Mirandola, M 2018, 'Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey', International Journal of Drug Policy, vol. 55, pp. 231-241. https://doi.org/10.1016/j.drugpo.2018.01.002

Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey. / Rosinska, M.; Gios, Lorenzo; Nöstlinger, Christiana; Vanden Berghe, Wim; Ulrich, Marcus; Schink, Susanne; Sherriff, Nigel; Jones, Anna-Marie; Folch, Cinta; Dias, Sonia; Velicko, Inga; Mirandola, Massimo.

In: International Journal of Drug Policy, Vol. 55, 07.05.2018, p. 231-241.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Prevalence of drug use during sex amongst MSM in Europe: results from a multi-site bio-behavioural survey

AU - Rosinska, M.

AU - Gios, Lorenzo

AU - Nöstlinger, Christiana

AU - Vanden Berghe, Wim

AU - Ulrich, Marcus

AU - Schink, Susanne

AU - Sherriff, Nigel

AU - Jones, Anna-Marie

AU - Folch, Cinta

AU - Dias, Sonia

AU - Velicko, Inga

AU - Mirandola, Massimo

N1 - © 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

PY - 2018/5/7

Y1 - 2018/5/7

N2 - Background Substance use has been consistently reported to be more prevalent amongst Men who have Sex with Men (MSM) compared to the general population. Substance use, in particular polydrug use, has been found to be influenced by social and contextual factors and to increase the risk of unprotected intercourse among MSM. The objective of this analysis was to investigate the prevalence and predictors of drug use during a sexual encounter and to identify specific prevention needs. Methods/Design A multi-site bio-behavioural cross-sectional survey was implemented in 13 European cities, targeting MSM and using Time-Location Sampling and Respondent-Driven Sampling methods. Multivariable multi-level logistic random-intercept model (random effect of study site) was estimated to identify factors associated with the use of alcohol, cannabis, party drugs, sexual performance enhancement drugs and chemsex drugs. Results Overall, 1,261 (30.0%) participants reported drug use, and 436 of 3,706 (11.8%) reported the use of two or more drugs during their last sexual encounter. By drug class, 966 (23.0%) reported using sexual performance enhancement drugs, 353 (8.4%) - party drugs, and 142 (3.4%) the use of chemsex drugs. Respondents who reported drug use were more frequently diagnosed with HIV (10.5% vs. 3.9%) before and with other STIs during the 12 months prior to the study (16.7% vs. 9.2%). The use of all the analysed substances was significantly associated with sexual encounter with more than one partner. Discussion Substance and polydrug use during sexual encounters occurred amongst sampled MSM across Europe although varying greatly between study sites. Different local social norms within MSM communities may be important contextual drivers of drug use, highlighting the need for innovative and multi-faceted prevention measures to reduce HIV/STI risk in the context of drug use.

AB - Background Substance use has been consistently reported to be more prevalent amongst Men who have Sex with Men (MSM) compared to the general population. Substance use, in particular polydrug use, has been found to be influenced by social and contextual factors and to increase the risk of unprotected intercourse among MSM. The objective of this analysis was to investigate the prevalence and predictors of drug use during a sexual encounter and to identify specific prevention needs. Methods/Design A multi-site bio-behavioural cross-sectional survey was implemented in 13 European cities, targeting MSM and using Time-Location Sampling and Respondent-Driven Sampling methods. Multivariable multi-level logistic random-intercept model (random effect of study site) was estimated to identify factors associated with the use of alcohol, cannabis, party drugs, sexual performance enhancement drugs and chemsex drugs. Results Overall, 1,261 (30.0%) participants reported drug use, and 436 of 3,706 (11.8%) reported the use of two or more drugs during their last sexual encounter. By drug class, 966 (23.0%) reported using sexual performance enhancement drugs, 353 (8.4%) - party drugs, and 142 (3.4%) the use of chemsex drugs. Respondents who reported drug use were more frequently diagnosed with HIV (10.5% vs. 3.9%) before and with other STIs during the 12 months prior to the study (16.7% vs. 9.2%). The use of all the analysed substances was significantly associated with sexual encounter with more than one partner. Discussion Substance and polydrug use during sexual encounters occurred amongst sampled MSM across Europe although varying greatly between study sites. Different local social norms within MSM communities may be important contextual drivers of drug use, highlighting the need for innovative and multi-faceted prevention measures to reduce HIV/STI risk in the context of drug use.

KW - MSM

KW - Drug use

KW - Recreational drug use

KW - Time-location sampling

KW - Respondent-driven sampling

KW - Europe

U2 - 10.1016/j.drugpo.2018.01.002

DO - 10.1016/j.drugpo.2018.01.002

M3 - Article

VL - 55

SP - 231

EP - 241

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

SN - 0955-3959

ER -